ArticleJournal of racial and ethnic health disparities2025
Factors Associated with Medication Adherence and Glycemic Control among American Indian/Alaska Native Adults with Type 2 Diabetes Within a Commercial Health Care System: A System-Wide Cross-Sectional Study.
Article in Journal of racial and ethnic health disparities, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionAmerican Indian and Alaska Native (AI/AN) adults experience type 2 diabetes (T2DM) at twice the rate of non-Hispanic White adults in the United States. Despite the importance of medication adherence for T2DM management, research in this area among AI/ANs is sparse, especially within the context of a commercial health care system. We sought to identify factors associated with medication adherence among AI/AN adults with T2DM and examined the relationship of adherence with glycemic control (hemoglobin A1C).
methodsThis cross-sectional study was conducted with patients from a commercial healthcare system. Data stemmed from online surveys completed by participants, paired with data from participants' electronic health records (EHRs). The World Health Organization Multidimensional Adherence Model was used to select potentially significant predictors of adherence (social determinants of health, patient-provider relationship, diabetes-related comorbidities, medication regimen complexity, outcome expectancies and self-efficacy). Linear regression and a mediator model were used.
resultsThe sample included n = 88 participants with an average A1C = 7.7. The multiple regression model revealed only age and self-efficacy as significant predictors of medication adherence, explaining 27% of its variability. Medication adherence explained 25% of the variability in A1C. In the mediator model, medication adherence fully mediated the relationship between self-efficacy and A1C.
conclusionAmong the many factors potentially related to medication adherence, self-efficacy was the only modifiable factor significantly associated with adherence. System- and individual-level interventions that target enhanced self-efficacy may have a meaningful impact on improved medication adherence and glycemic control.
Indexed as
Identifiers
41272286What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.